Evidence map›Paper›PMID 35407441›Full record

ArticleJournal of clinical medicine2022

Retinal Manifestations in Patients with COVID-19: A Prospective Cohort Study.

Eleonora Riotto, Vladimir Mégevand, Alexis Mégevand, Christophe Marti, Jerome Pugin, Alexandros N Stangos, Leonardo Marconi Archinto, Gordana Sunaric Mégevand

Abstract read
In one paragraph

Article in Journal of clinical medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Eleonora RiottoFaculty of Medicine, University Hospital Geneva, 1205 Geneva, Switzerland.ORCID 0000-0002-3593-2516
Vladimir MégevandDepartment of Surgery, University Hospital Geneva, 1205 Geneva, Switzerland.
Alexis MégevandFaculty of Medicine, University Hospital Geneva, 1205 Geneva, Switzerland.
Christophe MartiDepartment of Internal Medicine, University Hospital Geneva, 1205 Geneva, Switzerland.ORCID 0000-0002-2016-6759
Jerome PuginDepartment of Intensive Care, University Hospital Geneva, 1205 Geneva, Switzerland.ORCID 0000-0003-0265-5062
Alexandros N StangosClinical Eye Research Centre A. Rothschild, 1205 Geneva, Switzerland.
Leonardo Marconi ArchintoDepartment of Biology, Faculty of Science, Geneva University, 1205 Geneva, Switzerland.
Gordana Sunaric MégevandClinical Eye Research Centre A. Rothschild, 1205 Geneva, Switzerland.

Funding

Fondation Ophtalmologique Adolphe de Rothschild 202002873
6 · The paper itself

Abstract

The recent outbreak of the Coronavirus SARS-CoV-2 has been declared a worldwide pandemic. Within various multi-organ involvement, several ocular manifestations have been described, such as conjunctivitis and retinopathy. The prevalence and severity of retinal lesions and their relation to the severity of the systemic disease are unknown. We performed a prospective, observational study on 172 consecutively hospitalized patients with acute confirmed COVID-19 infection. All patients underwent screening widefield fundus photography at the time of hospital admission. Despite no ocular or vision-related symptoms, we found cotton wool spots (CWS) and/or hemorrhages in 19/172 patients (11%). Diabetes history, overweight, and elevated C-reactive protein were more frequently observed among patients with retinal abnormalities, while a history of systemic hypertension was more frequently observed among patients without retinal findings. At a 3-month follow-up visit, CWS had subsided in all patients.

Indexed as

cotton wool spotCOVIDOCTretinaretinal hemorrhagesretinopathySARS-CoV-2

Identifiers

PMID35407441
PMCPMC8999406

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.